Table 2.
Univariate and multivariate analysis of prognosis genes for TCGA CM.
| Training cohort | Univariate analysis | Multivariate analysis | ||||
|---|---|---|---|---|---|---|
| Genes | coef | HR (95%CI) | P | coef | HR (95%CI) | P |
| ADAMDEC1 | −0.098 | 0.906 (0.848–0.969) | 0.004 | −0.099 | 0.906 (0.845–0.971) | 0.005 |
| D2S69E | −0.084 | 0.919 (0.847–0.998) | 0.043 | −0.089 | 0.915 (0.839–0.998) | 0.045 |
| HSPA13 | −0.346 | 0.708 (0.594–0.844) | 0.000 | −0.251 | 0.778 (0.648–0.936) | 0.007 |
| TRIM29 | 0.088 | 1.092 (1.033–1.154) | 0.002 | 0.074 | 1.077 (1.017–1.141) | 0.011 |
| Validation cohort | Univariate analysis | Multivariate analysis | ||||
| Genes | coef | HR (95%CI) | P | coef | HR (95%CI) | P |
| ADAMDEC1 | −0.102 | 0.903 (0.852–0.958) | 0.000 | −0.113 | 0.893 (0.834–0.956) | 0.001 |
| D2S69E | −0.099 | 0.905 (0.843–0.971) | 0.006 | −0.092 | 0.090 (0.844–0.986) | 0.021 |
| HSPA13 | −0.232 | 0.793 (0.637–0.987) | 0.038 | −0.227 | 0.797 (0.641–0.991) | 0.042 |
| TRIM29 | 0.112 | 1.119 (1.066–1.174) | 0.000 | 0.101 | 1.106 (1.052–1.164) | 0.000 |
| Total | Univariate analysis | Multivariate analysis | ||||
| Genes | coef | HR (95%CI) | P | coef | HR (95%CI) | P |
| ADAMDEC1 | −0.101 | 0.905 (0.866–0.945) | 0.000 | −0.108 | 0.898 (0.857–0.940) | 0.000 |
| D2S69E | −0.091 | 0.913 (0.865–0.963) | 0.000 | −0.093 | 0.911 (0.862–0.964) | 0.000 |
| HSPA13 | −0.284 | 0.753 (0.657–0.864) | 0.000 | −0.264 | 0.768 (0.669–0.882) | 0.000 |
| TRIM29 | 0.102 | 1.108 (1.068–1.148) | 0.000 | 0.091 | 1.095 (1.055–1.136) | 0.000 |